STRS Ohio
LENZ icon

STRS Ohio’s LENZ Therapeutics LENZ Stock Holding History

STRS Ohio’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.9K Buy
+4,400
New +$21.9K ﹤0.01% 2165
2022
Q2 		– Sell
-1,000
Closed -$35K – 2330
2022
Q1 		$35K Buy
1,000
+471
+89% +$29.5K ﹤0.01% 1990
2021
Q4 		$45K Hold
529
– – ﹤0.01% 2019
2021
Q3 		$60K Buy
+529
New +$78.3K ﹤0.01% 2042

Other funds holding LENZ

KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Kestra Private Wealth Services
Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Indivisible Partners
Indivisible Partners Clearwater, Florida $2.18B AUM 33.61% 1-Year Est. Return
Kelleher Financial Advisors
Kelleher Financial Advisors New York $377M AUM 12.39% 1-Year Est. Return
Pinnacle Wealth Planning Services
Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

STRS Ohio's LENZ Position: Q3 2026 in Review

STRS Ohio opened a new position in LENZ Therapeutics (LENZ) in Q3 2026: 4,400 shares worth $16.9K. The stake represents ﹤0.01% of the portfolio and ranks #2165 among its holdings. This is a return to the name: STRS Ohio previously reported a position in LENZ as recently as Q1 2022.

STRS Ohio first reported a position in LENZ in Q3 2021 and has held it in 4 quarters since. The position peaked at $60K in Q3 2021. 25 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

  • STRS Ohio held 4,400 shares of LENZ Therapeutics worth $16.9K as of Q3 2026.
  • LENZ Therapeutics was a new STRS Ohio position in Q3 2026.
  • LENZ Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #2165 holding.
  • STRS Ohio first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 4 quarters since.
  • STRS Ohio's LENZ Therapeutics position peaked at $60K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.